抗IFN gamma(R4-6A2)体内抗体-低内毒素
货号:ICH1129-100mg
品牌:ichorbio
产品特性
Anti-IFN gamma (R4-6A2) In Vivo Antibody - Low Endotoxin is manufactured in an cGMP compliant facility.
内毒素: ≤ 1.0 EU/mg as determined by the LAL method
纯度: >95% by SDS-PAGE and HPLC
应用: ELISA Capture, ELISPOT, Neutralization, Immunohistochemistry - Frozen.
规格 | 价格 |
---|---|
100mg | ¥咨询 |
产品咨询:info@biopcr.com
产品订购:sales@biopcr.com
技术支持:tech@biopcr.com
服务热线:400-860-6200
详细介绍
产品名称:抗IFN gamma(R4-6A2)体内抗体-低内毒素
别名:抗IFN gamma体内抗体, 抗IFN gamma抗体-低内毒素, Anti-IFN gamma (R4-6A2) In Vivo Antibody - Low Endotoxin, Anti-IFN gamma In Vivo Antibody, Anti-IFN gamma Antibody - Low Endotoxin, Immune Interferon, Type II Interferon, T Cell Interferon, MAF, IFNG, IFG, IFI
宿主:Rat
应用:ELISA Capture, ELISPOT, Neutralization, Immunohistochemistry - Frozen
亚型:Rat IgG1 Kappa
克隆:R4-6A2
浓度:≥ 2.0 mg/ml
免疫原:Mouse interferon gamma
反应性:Mouse
特异性:An epitope on mouse interferon gamma
存储溶液:0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added.
储存条件:Stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
推荐同型对照(Isotype Control):Rat IgG1 Isotype Control for In Vivo - Low Endotoxin [GL113] (ICH2246)
推荐缓冲液(Buffer):体内抗体缓冲液pH7.4
靶点(Target): IFN-gamma
纯化方法(Purification method): This monoclonal antibody was purified using Protein G
纯度(Purity):>95% by SDS-PAGE and HPLC
内毒素(Endotoxin):≤ 1.0 EU/mg as determined by the LAL method
聚集(Aggregation):Aggregation level ≤ 5%
产品使用(Use):Products are for research use only. Not for use in diagnostic or therapeutic procedures.
运输条件:
返回列表
推荐缓冲液(Buffer):体内抗体缓冲液pH7.4
靶点(Target): IFN-gamma
纯化方法(Purification method): This monoclonal antibody was purified using Protein G
纯度(Purity):>95% by SDS-PAGE and HPLC
内毒素(Endotoxin):≤ 1.0 EU/mg as determined by the LAL method
聚集(Aggregation):Aggregation level ≤ 5%
产品使用(Use):Products are for research use only. Not for use in diagnostic or therapeutic procedures.
运输条件: